SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001469709-20-000006
Filing Date
2020-02-11
Accepted
2020-02-11 16:35:31
Documents
4
Period of Report
2020-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AGGX 8-K 02/11/20 aggx8k_021120apg.htm 8-K 26242
2 EXHIBIT 10.1 ex10_1apg.htm EX-10.1 150378
3 EXHIBIT 99.1 ex99_1apg.htm EX-99.1 8139
4 GRAPHIC ex99_1apg002.gif GRAPHIC 16839
  Complete submission text file 0001469709-20-000006.txt   209316
Mailing Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017
Business Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017 212-874-6608
AngioGenex, Inc. (Filer) CIK: 0001085596 (see all company filings)

IRS No.: 860945116 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26181 | Film No.: 20597130
SIC: 2834 Pharmaceutical Preparations